Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jennifer Moffatt, M. Harper, B. Adler, R. Nation, J. Li, J. Boyce (2011)
Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 55
S. Corvec, N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, A. Reynaud (2003)
AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains.The Journal of antimicrobial chemotherapy, 52 4
B. Speer, N. Shoemaker, A. Salyers (1992)
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significanceClinical Microbiology Reviews, 5
•• Description of the efficacy of mass spectrometry for the detection of carbapenemase in Acinetobacter
P. Mugnier, L. Poirel, T. Naas, P. Nordmann (2010)
Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1Emerging Infectious Diseases, 16
L. Poirel, S. Figueiredo, V. Cattoir, A. Carattoli, P. Nordmann (2008)
Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter sppAntimicrobial Agents and Chemotherapy, 52
P. Higgins, T. Schneiders, A. Hamprecht, H. Seifert (2010)
In Vivo Selection of a Missense Mutation in adeR and Conversion of the Novel blaOXA-164 Gene into blaOXA-58 in Carbapenem-Resistant Acinetobacter baumannii Isolates from a Hospitalized PatientAntimicrobial Agents and Chemotherapy, 54
L. Poirel, S. Corvec, M. Rapoport, P. Mugnier, A. Petroni, F. Pasteran, D. Faccone, M. Galas, H. Drugeon, V. Cattoir, P. Nordmann (2007)
Identification of the Novel Narrow-Spectrum β-Lactamase SCO-1 in Acinetobacter spp. from ArgentinaAntimicrobial Agents and Chemotherapy, 51
C. Franklin, L. Liolios, A. Peleg (2006)
Phenotypic Detection of Carbapenem-Susceptible Metallo-β-Lactamase-Producing Gram-Negative Bacilli in the Clinical LaboratoryJournal of Clinical Microbiology, 44
R. Bonnin, L. Poirel, T. Naas, M. Pirs, K. Seme, J. Schrenzel, P. Nordmann (2012)
Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18 9
M. García-Quintanilla, M. Pulido, R. López-Rojas, J. Pachón, M. McConnell (2013)
Emerging therapies for multidrug resistant Acinetobacter baumannii.Trends in microbiology, 21 3
L. Poirel, T. Naas, M. Guibert, E. Chaibi, R. Labia, P. Nordmann (1999)
Molecular and Biochemical Characterization of VEB-1, a Novel Class A Extended-Spectrum β-Lactamase Encoded by an Escherichia coli Integron GeneAntimicrobial Agents and Chemotherapy, 43
A. Tupin, Maxime Gualtieri, Françoise Roquet-Banères, Zakia Morichaud, K. Brodolin, J. Leonetti (2010)
Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns.International journal of antimicrobial agents, 35 6
R. Bonnin, T. Naas, L. Poirel, P. Nordmann (2012)
Phenotypic, Biochemical, and Molecular Techniques for Detection of Metallo-β-Lactamase NDM in Acinetobacter baumanniiJournal of Clinical Microbiology, 50
P. Higgins, L. Poirel, Marlene Lehmann, P. Nordmann, H. Seifert (2009)
OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 53
M. Kaase, P. Nordmann, T. Wichelhaus, S. Gatermann, R. Bonnin, L. Poirel (2011)
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.The Journal of antimicrobial chemotherapy, 66 6
P. Nordmann, L. Dortet, L. Poirel (2012)
Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in molecular medicine, 18 5
Yun Cai, D. Chai, Rui Wang, B. Liang, N. Bai (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.The Journal of antimicrobial chemotherapy, 67 7
K. Karthikeyan, M. Thirunarayan, P. Krishnan (2010)
Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India.The Journal of antimicrobial chemotherapy, 65 10
E. Bergogne-Bérézin (1997)
Treatment of Acinetobacter infections.Expert opinion on investigational drugs, 6 2
T. Jang, S.H. Lee, C.-H. Huang, Cl Lee, W.Y. Chen (2009)
Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.The Journal of hospital infection, 73 2
L. Poirel, R. Bonnin, P. Nordmann (2011)
Analysis of the Resistome of a Multidrug-Resistant NDM-1-Producing Escherichia coli Strain by High-Throughput Genome SequencingAntimicrobial Agents and Chemotherapy, 55
T. Naas, B. Coignard, A. Carbonne, K. Blanckaert, O. Bajolet, C. Bernet, X. Verdeil, P. Astagneau, J. Desenclos, P. Nordmann (2006)
VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.Emerging infectious diseases, 12 8
R. Bonnin, V. Rotimi, Mona Hubail, Elise Gasiorowski, N. Sweih, P. Nordmann, L. Poirel (2012)
Wide Dissemination of GES-Type Carbapenemases in Acinetobacter baumannii Isolates in KuwaitAntimicrobial Agents and Chemotherapy, 57
G. Bou, J. Martínez-Beltrán (2000)
Cloning, Nucleotide Sequencing, and Analysis of the Gene Encoding an AmpC β-Lactamase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 44
(2006)
French Nosocomial Infection Early Warning Investigation and Surveillance Network. VEB-1 Extended-spectrum β-lactamase-producing Acinetobacter baumannii
T. Naas, P. Bogaerts, C. Bauraing, Yves Degheldre, Y. Glupczynski, P. Nordmann (2006)
Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium.The Journal of antimicrobial chemotherapy, 58 1
B. Berçot, L. Poirel, P. Nordmann (2011)
Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers.Diagnostic microbiology and infectious disease, 71 4
L. Munoz-Price, R. Weinstein (2008)
Acinetobacter infection.The New England journal of medicine, 358 12
F. Pasteran, M. Rapoport, A. Petroni, D. Faccone, A. Corso, M. Galas, M. Vazquez, A. Procopio, M. Tokumoto, Viviana Cagnoni (2006)
Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the AmericasAntimicrobial Agents and Chemotherapy, 50
Maria Giannouli, A. Popolo, E. Durante-Mangoni, M. Bernardo, S. Cuccurullo, G. Amato, M. Tripodi, M. Triassi, R. Utili, R. Zarrilli (2012)
Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.International journal of antimicrobial agents, 39 1
M. Galimand, P. Courvalin, T. Lambert (2003)
Plasmid-Mediated High-Level Resistance to Aminoglycosides in Enterobacteriaceae Due to 16S rRNA MethylationAntimicrobial Agents and Chemotherapy, 47
S. Mahgoub, J. Ahmed, A. Glatt (2002)
Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii.American journal of infection control, 30 7
Y. Doi, E. Onuoha, J. Adams-Haduch, D. Pakstis, Traci McGaha, Carly Werner, B. Parker, M. Brooks, K. Shutt, A. Pasculle, Carlene Muto, L. Harrison (2010)
Screening for Acinetobacter baumannii Colonization by Use of SpongesJournal of Clinical Microbiology, 49
S. Figueiredo, S. Figueiredo, R. Bonnin, L. Poirel, Jacques Duranteau, P. Nordmann (2012)
Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18 9
C. Kulah, E. Aktaş, F. Comert, N. Ozlu, I. Akyar, H. Ankarali (2009)
Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAwayBMC Infectious Diseases, 9
Wei-hua Zhao, Zhi-qing Hu (2012)
Acinetobacter: A potential reservoir and dispenser for β-lactamasesCritical Reviews in Microbiology, 38
P. Nordmann, L. Poirel, A. Carrër, M. Toleman, T. Walsh (2010)
How To Detect NDM-1 ProducersJournal of Clinical Microbiology, 49
S. Figueiredo, L. Poirel, A. Papa, V. Koulourida, P. Nordmann (2009)
Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9Antimicrobial Agents and Chemotherapy, 53
J. Vila, S. Martí, J. Sánchez-Céspedes (2007)
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.The Journal of antimicrobial chemotherapy, 59 6
• Description of a novel method for screening A. baumannii in intensive care units
N. Nagano, Y. Nagano, C. Cordevant, N. Shibata, Y. Arakawa (2004)
Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward.Journal of clinical microbiology, 42 9
C. Moubareck, S. Brémont, M. Conroy, P. Courvalin, T. Lambert (2009)
GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 53
J. Li, C. Rayner, R. Nation, R. Owen, D. Spelman, K. Tan, L. Liolios (2006)
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 50
• Epidemiological study of extendedspectrum β-lactamase (ESBL)-producing A. baumannii causing a large outbreak in France
D. Vallenet, P. Nordmann, V. Barbe, L. Poirel, S. Mangenot, Elodie Bataille, C. Dossat, S. Gas, A. Kreimeyer, Patricia Lenoble, S. Oztas, J. Poulain, Béatrice Segurens, C. Robert, C. Abergel, J. Claverie, D. Raoult, C. Médigue, J. Weissenbach, S. Cruveiller (2008)
Comparative Analysis of Acinetobacters: Three Genomes for Three LifestylesPLoS ONE, 3
Guo-Bao Tian, J. Adams-Haduch, M. Taracila, R. Bonomo, Hong-ning Wang, Y. Doi (2011)
Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to CefepimeAntimicrobial Agents and Chemotherapy, 55
Review on the genetics of all acquired ESBL in Gram-negative rods
R. Bonnin, L. Poirel, T. Benoit-Cattin, P. Nordmann (2013)
Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago.International journal of antimicrobial agents, 41 3
Anna Mostachio, A. Levin, C. Rizek, F. Rossi, Jessika Zerbini, S. Costa (2012)
High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.International journal of antimicrobial agents, 39 5
P. Nordmann, L. Poirel (2005)
[Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae].Pathologie-biologie, 54 1
P. Fournier, D. Vallenet, V. Barbe, S. Audic, H. Ogata, L. Poirel, H. Richet, C. Robert, S. Mangenot, C. Abergel, P. Nordmann, J. Weissenbach, D. Raoult, J. Claverie (2006)
Comparative Genomics of Multidrug Resistance in Acinetobacter baumanniiPLoS Genetics, 2
A. Nemec, L. Křížová, M. Maixnerová, T. Reijden, P. Deschaght, Virginie Passet, Mario Vaneechoutte, S. Brisse, L. Dijkshoorn (2011)
Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).Research in microbiology, 162 4
P. Nordmann, L. Poirel, L. Dortet (2012)
Rapid Detection of Carbapenemase-producing EnterobacteriaceaeEmerging Infectious Diseases, 18
(2007)
Précis de Bactériologie Clinique (2nd Edition)
Y. Doi, Y. Arakawa (2007)
16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 45 1
Iraida Robledo, E. Aquino, G. Vázquez (2011)
Detection of the KPC Gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-Based Nosocomial Surveillance Study in Puerto RicoAntimicrobial Agents and Chemotherapy, 55
P. Bogaerts, G. Cuzon, T. Naas, C. Bauraing, A. Deplano, B. Lissoir, P. Nordmann, Y. Glupczynski (2008)
Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the blaOXA-23 Gene Associated with ISAba4 in BelgiumAntimicrobial Agents and Chemotherapy, 52
L. Poirel, R. Bonnin, A. Boulanger, J. Schrenzel, M. Kaase, P. Nordmann (2011)
Tn125-Related Acquisition of blaNDM-Like Genes in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 56
G. Celenza, C. Pellegrini, M. Caccamo, B. Segatore, G. Amicosante, M. Perilli (2006)
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitalsJournal of Antimicrobial Chemotherapy, 57
L. Poirel, T. Naas, P. Nordmann (2009)
Diversity, Epidemiology, and Genetics of Class D β-LactamasesAntimicrobial Agents and Chemotherapy, 54
M. Marques, E. Brookings, S. Moser, Phillip Sonke, K. Waites (1997)
Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinationsAntimicrobial Agents and Chemotherapy, 41
L. Poirel, R. Bonnin, P. Nordmann (2012)
Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 12 5
Caroline Dallenne, A. Costa, D. Decré, C. Favier, G. Arlet (2010)
Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.The Journal of antimicrobial chemotherapy, 65 3
L. Poirel, L. Cabanne, H. Vahaboğlu, P. Nordmann (2005)
Genetic Environment and Expression of the Extended-Spectrum β-Lactamase blaPER-1 Gene in Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 49
M. Adams, G. Nickel, S. Bajaksouzian, Heather Lavender, A. Murthy, M. Jacobs, R. Bonomo (2009)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component SystemAntimicrobial Agents and Chemotherapy, 53
J. Monteiro, R. Widen, A. Pignatari, Carly Kubasek, S. Silbert (2012)
Rapid detection of carbapenemase genes by multiplex real-time PCR.The Journal of antimicrobial chemotherapy, 67 4
L. Poirel, R. Bonnin, P. Nordmann (2011)
Genetic basis of antibiotic resistance in pathogenic Acinetobacter speciesIUBMB Life, 63
T. Naas, G. Cuzon, P. Bogaerts, Y. Glupczynski, P. Nordmann (2011)
Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 CarbapenemasesJournal of Clinical Microbiology, 49
J. Rodríguez-Martínez, P. Nordmann, E. Ronco, L. Poirel (2010)
Extended-Spectrum Cephalosporinase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 54
C. Héritier, L. Poirel, P. Nordmann (2006)
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 12 2
R. Cayô, M. Rodríguez, P. Espinal, F. Fernández-Cuenca, A. Ocampo-Sosa, Á. Pascual, J. Ayala, J. Vila, L. Martínez-Martínez (2011)
Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 55
Jennifer Moffatt, M. Harper, P. Harrison, J. Hale, E. Vinogradov, T. Seemann, R. Henry, B. Crane, F. Michael, A. Cox, B. Adler, R. Nation, J. Li, J. Boyce (2010)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide ProductionAntimicrobial Agents and Chemotherapy, 54
D. Landman, C. Georgescu, D. Martin, J. Quale (2008)
Polymyxins RevisitedClinical Microbiology Reviews, 21
N. Woodford, J. Turton, D. Livermore (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.FEMS microbiology reviews, 35 5
R. Mendes, Katia Kiyota, J. Monteiro, M. Castanheira, S. Andrade, A. Gales, A. Pignatari, S. Tufik (2006)
Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve AnalysisJournal of Clinical Microbiology, 45
T. Paavilainen, M. Alanen, Mika Mäkelä, M. Routamaa, H. Järvinen, P. Huovinen, P. Kotilainen (2001)
Infrequent Isolation of Multiresistant Acinetobacter baumannii From the Staff Tending a Colonized Patient With Severe BurnsInfection Control & Hospital Epidemiology, 22
Li-Yueh Huang, T.-L. Chen, T.-L. Chen, P. Lu, C. Tsai, W. Cho, F. Chang, C. Fung, C. Fung, L. Siu, L. Siu (2008)
Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 14 11
S. Figueiredo, L. Poirel, J. Croizé, C. Recule, P. Nordmann (2009)
In Vivo Selection of Reduced Susceptibility to Carbapenems in Acinetobacter baumannii Related to ISAba1-Mediated Overexpression of the Natural blaOXA-66 Oxacillinase GeneAntimicrobial Agents and Chemotherapy, 53
L. Poirel, L. Dortet, Sandrine Bernabeu, P. Nordmann (2011)
Genetic Features of blaNDM-1-Positive EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 55
A. Potron, L. Muñoz-Price, P. Nordmann, T. Cleary, L. Poirel (2011)
Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from HaitiAntimicrobial Agents and Chemotherapy, 55
L. Poirel, T. Walsh, Vincent Cuvillier, P. Nordmann (2011)
Multiplex PCR for detection of acquired carbapenemase genes.Diagnostic microbiology and infectious disease, 70 1
Kunikazu Yamane, J. Wachino, Y. Doi, H. Kurokawa, Y. Arakawa (2005)
Global Spread of Multiple Aminoglycoside Resistance GenesEmerging Infectious Diseases, 11
M. Kempf, J. Rolain, G. Diatta, S. Azza, Bissoume Samb, O. Mediannikov, Amy Sow, S. Diene, F. Fenollar, D. Raoult (2012)
Carbapenem Resistance and Acinetobacter baumannii in Senegal: The Paradigm of a Common Phenomenon in Natural ReservoirsPLoS ONE, 7
T. Walsh, M. Toleman, L. Poirel, P. Nordmann (2005)
Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 18
Kyungwon Lee, Y. Lim, D. Yong, J. Yum, Y. Chong (2003)
Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-β-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter sppJournal of Clinical Microbiology, 41
R. Bonnin, P. Nordmann, A. Potron, H. Lécuyer, J. Zahar, L. Poirel (2010)
Carbapenem-Hydrolyzing GES-Type Extended-Spectrum β-Lactamase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 55
D. Wareham, N. Gordon (2010)
Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumanniiJournal of Clinical Pathology, 64
J. Turton, M. Ward, N. Woodford, M. Kaufmann, R. Pike, D. Livermore, T. Pitt (2006)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.FEMS microbiology letters, 258 1
P. Bogaerts, T. Naas, F. Garch, G. Cuzon, A. Deplano, T. Delaire, Te-Din Huang, B. Lissoir, P. Nordmann, Y. Glupczynski (2010)
GES Extended-Spectrum β-Lactamases in Acinetobacter baumannii Isolates in BelgiumAntimicrobial Agents and Chemotherapy, 54
R. Bonnin, A. Potron, L. Poirel, H. Lécuyer, R. Neri, P. Nordmann (2011)
PER-7, an Extended-Spectrum β-Lactamase with Increased Activity toward Broad-Spectrum Cephalosporins in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 55
J. Adams-Haduch, D. Paterson, H. Sidjabat, A. Pasculle, B. Potoski, Carlene Muto, L. Harrison, Y. Doi (2008)
Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in PennsylvaniaAntimicrobial Agents and Chemotherapy, 52
S. Corvec, L. Poirel, T. Naas, H. Drugeon, P. Nordmann (2007)
Genetics and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-23 in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 51
R. López-Rojas, F. Docobo-Pérez, M. Pachón-Ibáñez, B. Torre, M. Fernández‐Reyes, Catalina March, J. Bengoechea, David Andreu, Lourdes Rivas, J. Pachón (2011)
Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumanniiEuropean Journal of Clinical Microbiology & Infectious Diseases, 30
The only current example of a resistance gene originating from an Acinetobacter species and targeting another Acinetobacter species
C. Héritier, L. Poirel, T. Lambert, P. Nordmann (2005)
Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 49
L. Dortet, L. Poirel, P. Nordmann (2012)
Rapid Detection of Carbapenemase-Producing Pseudomonas sppJournal of Clinical Microbiology, 50
• First description of the bla GES gene in A. baumannii
Sandrine Bernabeu, L. Poirel, P. Nordmann (2012)
Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae.Diagnostic microbiology and infectious disease, 74 1
A. Peleg, H. Seifert, D. Paterson (2008)
Acinetobacter baumannii: Emergence of a Successful PathogenClinical Microbiology Reviews, 21
Ronald Jones, M. Ferraro, L. Reller, P. Schreckenberger, J. Swenson, H. Sader (2006)
Multicenter Studies of Tigecycline Disk Diffusion Susceptibility Results for Acinetobacter sppJournal of Clinical Microbiology, 45
Yan Chen, Zhi-hui Zhou, Yan Jiang, Yunsong Yu (2011)
Emergence of NDM-1-producing Acinetobacter baumannii in China.The Journal of antimicrobial chemotherapy, 66 6
An epidemiological study of the most important carbapenemase in A. baumannii (OXA-23), giving all of the genetic features of an international collection of A
M. Joly-Guillou (2005)
Clinical impact and pathogenicity of Acinetobacter.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 11 11
Sébastien Coyne, P. Courvalin, B. Périchon (2010)
Efflux-Mediated Antibiotic Resistance in Acinetobacter sppAntimicrobial Agents and Chemotherapy, 55
Hongjiang Yang, L. Liang, Shu-xiang Lin, S. Jia (2010)
Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumanniiBMC Microbiology, 10
E. Bergogne-Bérézin, K. Towner (1996)
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 9
F. Pérez, A. Hujer, K. Hujer, B. Decker, P. Rather, R. Bonomo (2007)
Global Challenge of Multidrug-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 51
Another interesting paper on colistin resistance, discussing a novel method of resistance
• First epidemiological study of an international collection of New Delhi metallo-b-lactamase-producing A. baumannii
Acinetobacter baumannii, recognized as a serious threat in healthcare facilities, has the ability to develop resistance to antibiotics quite easily. This resistance is related to either gene acquisition (horizontal gene transfer) or mutations in the genome, leading to gene disruption, over- or down-expression of genes. The clinically relevant antibiotic resistances in A. baumannii include resistance to aminoglycosides, broad-spectrum cephalosporins, carbapenems, tigecycline and colistin, which are the last resort antibiotics. The intrinsic and acquired resistance mechanisms of A. baumannii are presented here, with special focus on β-lactam resistance. The most up-to-date techniques for identification, including phenotypical and molecular tests, and screening of those emerging resistance traits are also highlighted. The implementation of early detection and identification of multidrug-resistant A. baumannii is crucial to control their spread.
Expert Review of Anti-infective Therapy – Taylor & Francis
Published: Jun 1, 2013
Keywords: β-lactamases; Acinetobacter baumannii; carbapenemase; detection; resistance
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.